findmyKOL

Ruanne Barnabas, MBChB

Enriched profile

Chief, Division of Infectious Diseases, Massachusetts General Hospital · Massachusetts General Hospital

ORCIDNPI
Region🇺🇸 Boston, MA · Northeast · United StatesSpecialtyInfectious DiseaseFocusHIV/AIDS Research and Interventions+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceverified 2026Payments2022–2025NIH funding2015–2025

Ruanne Barnabas is Chief, Division of Infectious Diseases, Massachusetts General Hospital at Massachusetts General Hospital. OpenAlex indexes 335 publications with 10,107 citations (h-index 53); ClinicalTrials.gov lists 8 registered studies with this person as an investigator.

Data verified 17 Aug 2026

Overview

Updated 27 Aug 2026

Ruanne Barnabas, MBCHB., D.PHIL., is Chief, Division of Infectious Diseases, Massachusetts General Hospital. The public record shows 335 publications with 10,107 citations (h-index 53), centered on HIV/AIDS Research and Interventions, Cervical Cancer and HPV Research, Adolescent Sexual and Reproductive Health. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 2 companies, 5 NIH-funded awards (2015–2025).

  • Top research focus: HIV/AIDS Research and Interventions
  • 8 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 2 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
HIV5 trialsPapilloma2 trialsCOVID-192 trialsSevere Acute Respiratory Syndrome2 trialsHIV Infections1 trialVirus Diseases1 trialPapillomavirus Infections1 trial

Research focus

OpenAlex concept fingerprint
HIV/AIDS Research and InterventionsCervical Cancer and HPV ResearchAdolescent Sexual and Reproductive HealthHIV Research and TreatmentHIV, Drug Use, Sexual Risk

Works with

trial sponsors and companies reporting payments
Gilead Sciences, Inc.Clinical trialsIndustry payments8Massachusetts General HospitalClinical trials4Industry paymentsUniversity of WashingtonClinical trials4Industry payments

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
335publications

Distinct works indexed by OpenAlex, matched via ORCID; 26 in PubMed.

10,107citations

Total citations across indexed works.

53h-index

Hirsch index (OpenAlex). i10-index 161.

Clinical & industry

trials, payments and federal funding
8clinical trials

Investigator role on registered studies.

View trials
2companies · 2022–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
5NIH grants · 2015–2025

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

2 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2022)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    59.2%
    Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor29.6%
    Descovy100%
    Part D<11 patients
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor29.6%
    Tivicay100%
    Part D<11 patients
  • Cardiovascular

    40.8%
    Statin25.4%
    Atorvastatin Calcium100%
    Part D<11 patients
    Calcium channel blocker15.5%
    Amlodipine Besylate100%
    Part D<11 patients

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

5 NIH research awards on record, funded 20152025 per NIH RePORTER. The latest:

Congress activity

Updated 27 Aug 2026

1 congress contribution (2022) across ADA per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/ruanne-barnabas-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com

Mentions by others

where others cite or feature them
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MBChB

    MSc, DPhil

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →advances.massgeneral.org

Awards & honors

honors on the public record
  • Elected Member

    American Society for Clinical Investigation

    2024
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →data.the-asci.org
  • Minority Faculty Mentoring Award

    UW School of Medicine Committee on Minority Faculty Advancement

    2021
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mednews.uw.edu
  • Elected Fellow

    Infectious Diseases Society of America (IDSA)

    2020
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →globalhealth.uw.edu
2 more awards behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution
  • Professor of Epidemiology

    Harvard T.H. Chan School of Public Health

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hsph.harvard.edu
  • Professor of Medicine

    Harvard Medical School

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iasusa.org

Media & interviews

press, podcasts and appearances
  • Guest

    "Going anti-Viral" podcast (IAS-USA), Episode 68, "Strategic and Resilient Responses to the Funding Crisis Across Africa," discussing the CROI symposium on HIV funding cuts and PEPFAR

    2026
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iasusa.org

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.